Bhargava Rahul, Kumar Prachi, Bashir Hafsa, Sharma Shiv Kumar, Mishra Anurag
Department of Ophthalmology, Santosh Medical College and Hospital, Ghaziabad, Uttar Pradesh, India.
Department of Pathology, Santosh Medical College and Hospital, Ghaziabad, Uttar Pradesh, India.
Middle East Afr J Ophthalmol. 2014 Jan-Mar;21(1):77-82. doi: 10.4103/0974-9233.124110.
The purpose of this study is to evaluate the outcome of manual small incision cataract surgery (SICS) in eyes with uveitic cataract.
Medical college hospital of the subcontinent.
Retrospective case series.
In this retrospective study, patients who underwent SICS with posterior chamber intraocular lens implantation for uveitic cataract from 2006 to 2009 were evaluated. Patients with less than 3 months follow-up were excluded. Post-operative vision and complications were analyzed.
A total of 54 patients completed the study. The mean age was 52.3 ± 9.3 years. The mean follow-up was 11.53 ± 5.05 months. The mean surgical time was (10.2 ± 3.8 min). Etiological diagnosis was possible in 31.41% (17/54) of patients. There was a statistically significant improvement in vision after surgery (P < 0.001). When uveitis was well-controlled, pre-operative corticosteroids did not change post-operative inflammation (P = 0.796). However, pre-operative corticosteroids were statistically significantly associated to final best corrected visual acuity (BCVA) (P = 0.010).
SICS with posterior chamber intraocular lens implantation is safe in most cataracts due to uveitis and improves BCVA at 6 months. Inflammation should be well-controlled pre-operatively for at least 3 months. Posterior capsule opacification, macular edema and persistent uveitis were the main factors affecting visual outcome. SICS requires minimal instrumentation, surgical time is short and can also be performed in rural clinics and eye-camps, where phacoemulsification machines are unavailable. SICS may be a more practical and cost-effective technique for uveitic cataract, in such circumstances.
本研究旨在评估小切口白内障囊外摘除术（SICS）治疗葡萄膜炎性白内障的效果。
次大陆的医学院附属医院。
回顾性病例系列研究。
在这项回顾性研究中，对2006年至2009年接受SICS联合后房型人工晶状体植入术治疗葡萄膜炎性白内障的患者进行评估。随访时间少于3个月的患者被排除。分析术后视力和并发症。
共有54例患者完成研究。平均年龄为52.3±9.3岁。平均随访时间为11.53±5.05个月。平均手术时间为（10.2±3.8分钟）。31.41%（17/54）的患者能够明确病因诊断。术后视力有统计学显著改善（P<0.001）。当葡萄膜炎得到良好控制时，术前使用皮质类固醇并未改变术后炎症反应（P = 0.796）。然而，术前使用皮质类固醇与最终最佳矫正视力（BCVA）有统计学显著相关性（P = 0.010）。
SICS联合后房型人工晶状体植入术治疗大多数葡萄膜炎性白内障是安全的，且术后6个月可提高BCVA。术前应将炎症至少良好控制3个月。后囊膜混浊、黄斑水肿和持续性葡萄膜炎是影响视力预后的主要因素。SICS所需器械最少，手术时间短，在没有超声乳化仪的农村诊所和眼科营地也可进行。在这种情况下，SICS对于葡萄膜炎性白内障可能是一种更实用且经济有效的技术。
